HANNIBAL THERAPEUTICS AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−6k kr).

HANNIBAL THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 835570932. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2025. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Utvikling av legemidler mot alvorlige sykdommer.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −6,000 in operating profit.

Key figures · 2025

Revenue

NOK 0

Operating profit

NOK −6,000

Equity

NOK 17,000

Est. value

NOK 28,000

Financial health · 2025

Liquidity

–

Not available

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

100.0%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns HANNIBAL THERAPEUTICS AS?

Bjarte Håvik Private shareholder

100.0%

HANNIBAL THERAPEUTICS AS

NOK 0 rev. · NOK −6,000 profit

HANNIBAL THERAPEUTICS AS has 1 registered shareholder:

• Bjarte Håvik 100.0%

All shareholders and roles →

Frequently asked questions about HANNIBAL THERAPEUTICS AS

Who owns HANNIBAL THERAPEUTICS AS?

Bjarte Håvik is the largest registered owner, with 100.0%.

What is the revenue of HANNIBAL THERAPEUTICS AS?

HANNIBAL THERAPEUTICS AS had revenue of NOK 0 in 2025.

Who is the general manager of HANNIBAL THERAPEUTICS AS?

Bjarte Håvik is registered as general manager of HANNIBAL THERAPEUTICS AS.

Where is HANNIBAL THERAPEUTICS AS based?

HANNIBAL THERAPEUTICS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.